Oxurion NV: Oxurion Announces Second Amendment to Negma Funding Program
Oxurion Announces Second Amendment to Negma Funding Program Leuven, BELGIUM, Boston, MA, US - January 25, 2023 8:30 am - Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical
Stay updated with breaking news from Tom Graney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Oxurion Announces Second Amendment to Negma Funding Program Leuven, BELGIUM, Boston, MA, US - January 25, 2023 8:30 am - Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical
Investegate announcements from Oxurion NV, Oxurion Announces Second Amendment to Negma Funding Program
Negma Group has converted 80 convertible bonds in Oxurion resulting in a EUR 200,000 capital increase. This is part of Negma Group's EUR 30 million Capital Commitment1 that will allow Oxurion
Investegate announcements from Oxurion NV, Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA
Negma Group has converted 322 convertible bonds in Oxurion resulting in a EUR 805,000 capital increase. This is part of Negma Group's EUR 30 million Capital Commitment1 that will allow Oxurion